Peptide Therapeutics Market Size, Share & Trends Report

Peptide Therapeutics Market Size, Share & Trends Analysis Report By Application, By Type, By Type of Manufacturers, By Route of Administration, By Synthesis Technology, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: 978-1-68038-179-5
  • Number of Pages: 85
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology
                   1.1 Country-wise market: Base estimates
                   1.2 Global market: CAGR calculation
                   1.3 Region based segment share calculation
                   1.4 Research Scope & Assumptions
                   1.5 List of Data Sources
                       1.5.1 Data for primary interviews, by sources
                       1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
                   2.1 Market Snapshot
Chapter 3 Peptide Therapeutics Market Variables, Trends & Scope
                   3.1 Market segmentation & scope
                   3.2 Market Driver Analysis
                       3.2.1 Increasing prevalence of cancer
                       3.2.2 Rising incidences of metabolic disorder
                       3.2.3 Presence of strong product pipeline portfolio
                       3.2.4 Technological Advancement
                   3.3 Market restraint analysis
                       3.3.1 Stringent regulations
                   3.4 Key Opportunities Prioritized
                       3.4.1 Key opportunities prioritized
                   3.5 Peptide Therapeutics Market - SWOT Analysis, By Factor (political & legal, economic and technological)
                   3.6 Industry Analysis - Porter’s
Chapter 4 Peptide Therapeutics Market: Application Estimates & Trend Analysis
                   4.1 Peptide Therapeutics market: Application movement analysis
                   4.2 Cancer
                       4.2.1 Cancer market, 2017 - 2030 (USD Million)
                   4.3 Metabolic
                       4.3.1 Metabolic market, 2017 - 2030 (USD Million)
                   4.4 Cardiovascular Disorder
                       4.4.1 Cardiovascular Disorder market, 2017 - 2030 (USD Million)
                   4.5 Respiratory
                       4.5.1 Respiratory market, 2017 - 2030 (USD Million)
                   4.6 GIT
                       4.6.1 GIT market, 2017 - 2030 (USD Million)
                   4.7 Anti-infection
                       4.7.1 Anti-infection market, 2017 - 2030 (USD Million)
                   4.8 Pain
                       4.8.1 Pain market, 2017 - 2030 (USD Million)
                   4.9 Dermatology
                       4.9.1 Dermatology market, 2017 - 2030 (USD Million)
                   4.10 CNS
                       4.10.1 CNS market, 2017 - 2030 (USD Million)
                   4.11 Renal
                       4.11.1 Renal market, 2017 - 2030 (USD Million)
                   4.12 Others
                       4.12.1 Others market, 2017 - 2030 (USD Million)
Chapter 5 Peptide Therapeutics Market: Type Estimates & Trend Analysis
                   5.1 Peptide Therapeutics market: Type movement analysis
                   5.2 Generic
                       5.2.1 Generic Market, 2017 - 2030 (USD Million)
                   5.3 Innovative
                       5.3.1 Innovative Market, 2017 - 2030 (USD Million)
Chapter 6 Peptide Therapeutics Market: Type of Manufacturers Estimates & Trend Analysis
                   6.1 Peptide Therapeutics market: Type of Manufacturers movement analysis
                   6.2 In-house
                       6.2.1 In-house market, 2017 - 2030 (USD Million)
                   6.3 Outsourced
                       6.3.1 Outsourced market, 2017 - 2030 (USD Million)
Chapter 7 Peptide Therapeutics Market Route of Administration Estimates & Trend Analysis
                   7.1 Peptide Therapeutics market: Route of Administration movement analysis
                   7.2 Parenteral
                       7.2.1 Parenteral market, 2017 - 2030 (USD Million)
                   7.3 Oral
                       7.3.1 Oral market, 2017 - 2030 (USD Million)
                   7.4 Pulmonary
                       7.4.1 Pulmonary market, 2017 - 2030 (USD Million)
                   7.5 Mucosal
                       7.5.1 Mucosal market, 2017 - 2030 (USD Million)
                   7.6 Others
                       7.6.1 Others market, 2017 - 2030 (USD Million)
Chapter 8 Peptide Therapeutics Market Synthesis Technology Estimates & Trend Analysis
                   8.1 Peptide Therapeutics market: Synthesis Technology movement analysis
                   8.2 Solid Phase Peptide Synthesis (SPPS)
                       8.2.1 Solid Phase Peptide Synthesis (SPPS) market, 2017 - 2030 (USD Million)
                   8.3 Liquid Phase Peptide Synthesis (LPPS)
                       8.3.1 Liquid Phase Peptide Synthesis (LPPS) market, 2017 - 2030 (USD Million)
                   8.4 Hybrid Technology
                       8.4.1 Hybrid Technology market, 2017 - 2030 (USD Million)
Chapter 9 Peptide Therapeutics Market: Regional Estimates & Trend Analysis, by Source, Product, Application
                   9.1 Peptide Therapeutics market share by region, 2021 & 2030
                   9.2 North America
                       9.2.1 North America Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.2.2 U.S.
                           9.2.2.1 U.S. Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.2.3 Canada
                           9.2.3.1 Canada Peptide Therapeutics market, 2017 - 2030 (USD Million)
                   9.3 Europe
                       9.3.1 Europe Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.3.2 U.K.
                           9.3.2.1 U.K. Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.3.3 Germany
                           9.3.3.1 Germany Peptide Therapeutics market, 2017 - 2030 (USD Million)
                   9.4 Asia Pacific
                       9.4.1 Asia Pacific Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.4.2 Japan
                           9.4.2.1 Japan Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.4.3 China
                           9.4.3.1 China Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.4.4 India
                           9.4.4.1 India Peptide Therapeutics market, 2017 - 2030 (USD Million)
                   9.5 Latin America
                       9.5.1 Latin America Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.5.2 Brazil
                           9.5.2.1 Brazil Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.5.3 Mexico
                           9.5.3.1 Mexico Peptide Therapeutics market, 2017 - 2030 (USD Million)
                   9.6 MEA
                       9.6.1 MEA Peptide Therapeutics market, 2017 - 2030 (USD Million)
                       9.6.2 South Africa
                           9.6.2.1 South Africa Peptide Therapeutics market, 2017 - 2030 (USD Million)
Chapter 10 Competitive Landscape
                   10.1 Strategy Framework
                   10.2 Market Participation
                   10.3 Company Profiles
                       10.3.1 Bachem Holding AG
                           10.3.1.1 Company overview
                           10.3.1.2 Financial performance
                           10.3.1.3 Product benchmarking
                           10.3.1.4 Strategic initiatives
                       10.3.2 Eli Lilly and Company
                           10.3.2.1 Company overview
                           10.3.2.2 Financial performance
                           10.3.2.3 Product benchmarking
                           10.3.2.4 Strategic initiatives
                       10.3.3 Pfizer Inc.
                           10.3.3.1 Company overview
                           10.3.3.2 Financial performance
                           10.3.3.3 Product benchmarking
                           10.3.3.4 Strategic initiatives
                       10.3.4 Amgen Inc.
                           10.3.4.1 Company overview
                           10.3.4.2 Financial performance
                           10.3.4.3 Product benchmarking
                           10.3.4.4 Strategic initiatives
                       10.3.5 Takeda Pharmaceutical Company Limited
                           10.3.5.1 Company overview
                           10.3.5.2 Financial performance
                           10.3.5.3 Product benchmarking
                           10.3.5.4 Strategic initiatives
                       10.3.6 Teva Pharmaceutical
                           10.3.6.1 Company overview
                           10.3.6.2 Financial performance
                           10.3.6.3 Product benchmarking
                           10.3.6.4 Strategic initiatives
                       10.3.7 Lonza Inc.
                           10.3.7.1 Company overview
                           10.3.7.2 Financial performance
                           10.3.7.3 Product benchmarking
                           10.3.7.4 Strategic initiatives
                       10.3.8 Sanofi
                           10.3.8.1 Company overview
                           10.3.8.2 Financial performance
                           10.3.8.3 Product benchmarking
                           10.3.8.4 Strategic initiatives
                       10.3.9 Bristol-Myers Squibb(BMS)
                           10.3.9.1 Company overview
                           10.3.9.2 Financial performance
                           10.3.9.3 Product benchmarking
                           10.3.9.4 Strategic initiatives
                       10.3.10 AstraZeneca PLC
                           10.3.10.1 Company overview
                           10.3.10.2 Financial performance
                           10.3.10.3 Product benchmarking
                           10.3.10.4 Strategic initiatives
                       10.3.11 GlaxoSmithKline (GSK)
                           10.3.11.1 Company overview
                           10.3.11.2 Financial performance
                           10.3.11.3 Product benchmarking
                           10.3.11.4 Strategic initiatives
                       10.3.12 Novartis AG
                           10.3.12.1 Company overview
                           10.3.12.2 Financial performance
                           10.3.12.3 Product benchmarking
                           10.3.12.4 Strategic initiatives
                       10.3.13 Novo Nordisk A/S
                           10.3.13.1 Company overview
                           10.3.13.2 Financial performance
                           10.3.13.3 Product benchmarking
                           10.3.13.4 Strategic initiatives


List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 List of secondary data sources
TABLE 3 Primary interview details, by source
TABLE 4 Primary interview details, by region
TABLE 5 North America Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 6 North America Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 7 North America Peptide Therapeutics market, by type of manufacturers, 2017 - 2030 (USD Million)
TABLE 8 North America Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 9 North America Peptide Therapeutics market, synthesis technology, 2017 - 2030 (USD Million)
TABLE 10 U.S. Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 11 U.S. Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 12 U.S. Peptide Therapeutics market, by type of manufacturers, 2017 - 2030 (USD Million)
TABLE 13 U.S. Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 14 U.S. Peptide Therapeutics market, synthesis technology, 2017 - 2030 (USD Million)
TABLE 15 Canada Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 16 Canada Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 17 Canada Peptide Therapeutics market, by type of manufacturers, 2017 - 2030 (USD Million)
TABLE 18 Canada Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 19 Canada Peptide Therapeutics market, synthesis technology, 2017 - 2030 (USD Million)
TABLE 20 Europe Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 21 Europe Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 22 Europe Peptide Therapeutics market, by type of manufacturers, 2017 - 2030 (USD Million)
TABLE 23 Europe Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 24 Europe Peptide Therapeutics Market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 25 U.K. Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 26 U.K. Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 27 U.K. Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 28 U.K. Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 29 U.K. Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 30 Germany Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 31 Germany Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 32 Germany Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 33 Germany Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 34 Germany Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 35 Asia Pacific Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 36 Asia Pacific Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 37 Asia Pacific Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 38 Asia Pacific Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 39 Asia Pacific Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 40 Japan Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 41 Japan Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 42 Japan Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 43 Japan Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 44 Japan Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 45 China Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 46 China Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 47 China Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 48 China Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 49 China Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 50 India Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 51 India Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 52 India Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 53 India Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 54 India Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 55 Latin America Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 56 Latin America Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 57 Latin America Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 58 Latin America Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 59 Latin America Peptide Therapeutics Market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 60 Brazil America Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 61 Brazil Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 62 Brazil Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 63 Brazil Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 64 Brazil Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 65 Mexico America Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 66 Mexico Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 67 Mexico Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 68 Mexico Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 69 Mexico Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 70 MEA America Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 71 MEA Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 72 MEA Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 73 MEA Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 74 MEA Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)
TABLE 75 South Africa Peptide Therapeutics market, by application, 2017 - 2030 (USD Million)
TABLE 76 South Africa Peptide Therapeutics market, by type, 2017 - 2030 (USD Million)
TABLE 77 South Africa Peptide Therapeutics market, by type of administration, 2017 - 2030 (USD Million)
TABLE 78 South Africa Peptide Therapeutics market, by route of administration, 2017 - 2030 (USD Million)
TABLE 79 South Africa Peptide Therapeutics market, by synthesis technology, 2017 - 2030 (USD Million)


List of Figures

FIG. 1 Primary interviews, by sources
FIG. 2 Market summary
FIG. 3 Market trends & outlook
FIG. 4 Market segmentation & scope
FIG. 5 Market driver relevance analysis (Current & future impact)
FIG. 6 Market restraint relevance analysis (Current & future impact)
FIG. 7 Key opportunities prioritized
FIG. 8 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 9 Porter’s Five Forces Analysis
FIG. 10 Peptide Therapeutics market, Application outlook: Key takeaways
FIG. 11 Peptide Therapeutics market: Application movement analysis
FIG. 12 Cancer market, 2017 - 2030 (USD Million)
FIG. 13 Metabolic market, 2017 - 2030 (USD Million)
FIG. 14 Cardiovascular Disorder market, 2017 - 2030 (USD Million)
FIG. 15 Respiratory market, 2017 - 2030 (USD Million)
FIG. 16 GIT market, 2017 - 2030 (USD Million)
FIG. 17 Anti-infection market, 2017 - 2030 (USD Million)
FIG. 18 Pain market, 2017 - 2030 (USD Million)
FIG. 19 Dermatology market, 2017 - 2030 (USD Million)
FIG. 20 CNS market, 2017 - 2030 (USD Million)
FIG. 21 Renal market, 2017 - 2030 (USD Million)
FIG. 22 Others market, 2017 - 2030 (USD Million)
FIG. 23 Peptide Therapeutics market, type outlook: Key takeaways
FIG. 24 Peptide Therapeutics Market: Type movement analysis
FIG. 25 Generic market, 2017 - 2030 (USD Million)
FIG. 26 Innovative market, 2017 - 2030 (USD Million)
FIG. 27 Peptide Therapeutics market, Type of Manufacturers outlook: Key takeaways
FIG. 28 Peptide Therapeutics Market: Type of Manufacturers movement analysis
FIG. 29 In-house market, 2017 - 2030 (USD Million)
FIG. 30 Outsourced market, 2017 - 2030 (USD Million)
FIG. 31 Peptide Therapeutics market, Route of Administration outlook: Key takeaways
FIG. 32 Peptide Therapeutics Market: Route of Administration movement analysis
FIG. 33 Parental market, 2017 - 2030 (USD Million)
FIG. 34 Oral market, 2017 - 2030 (USD Million)
FIG. 35 Pulmonary market, 2017 - 2030 (USD Million)
FIG. 36 Mucosal market, 2017 - 2030 (USD Million)
FIG. 37 Others market, 2017 - 2030 (USD Million)
FIG. 38 Peptide Therapeutics market, Synthesis Technology outlook: Key takeaways
FIG. 39 Peptide Therapeutics Market: Synthesis Technology movement analysis
FIG. 40 Solid Phase Peptide Synthesis (SPPS) market, 2017 - 2030 (USD Million)
FIG. 41 Liquid Phase Peptide Synthesis (LPPS) market, 2017 - 2030 (USD Million)
FIG. 42 Hybrid Technology market, 2017 - 2030 (USD Million)
FIG. 43 Regional market place: Key takeaways
FIG. 44 Regional outlook, 2021 & 2030
FIG. 45 Strategy framework
FIG. 46 Market participation and categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.